{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:35:00Z","timestamp":1778700900438,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jpba.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T02:45:40Z","timestamp":1386816340000},"page":"192-197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Development and validation of a high performance liquid chromatography assay for the determination of temocillin in serum of haemodialysis patients"],"prefix":"10.1016","volume":"90","author":[{"given":"Ana C.","family":"Miranda Bastos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefaan J.","family":"Vandecasteele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Tulkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Van Bambeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.12.002_bib0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/AAC.22.3.453","article-title":"Antibacterial activity and beta-lactamase stability of temocillin","volume":"22","author":"Jules","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2013.12.002_bib0010","series-title":"Temocillin Summary of Product Characteristics. UK Medicines and Healthcare products Regulatory Agency (MHRA): Electronic Medicines Compendium (eMc)","year":"2012"},{"key":"10.1016\/j.jpba.2013.12.002_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dkn511","article-title":"Temocillin revived","volume":"63","author":"Livermore","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl. 5","key":"10.1016\/j.jpba.2013.12.002_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2165\/00003495-198500295-00032","article-title":"Human pharmacokinetics and antimicrobial activities of the temocillin epimers","volume":"29","author":"Guest","year":"1985","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2013.12.002_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijantimicag.2012.10.002","article-title":"Beta-lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia","volume":"41","author":"Hayashi","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2013.12.002_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/AAC.24.4.529","article-title":"Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis","volume":"24","author":"Cohen","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2013.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00216-012-6636-9","article-title":"A novel UPLC-MS\u2013MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients","volume":"405","author":"Boelaert","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2013.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.jpba.2013.12.002_bib0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/jac\/dkm467","article-title":"Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection","volume":"61","author":"De Jongh","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2013.12.002_bib0050","first-page":"579","article-title":"Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal \u2013 Part I","volume":"36","author":"Hubert","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.12.002_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpba.2007.06.013","article-title":"Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal \u2013 Part II","volume":"45","author":"Hubert","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.12.002_bib0060","series-title":"Guidance for Industry: Bioanalytical Method Validation","year":"2001"},{"key":"10.1016\/j.jpba.2013.12.002_bib0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chroma.2007.03.102","article-title":"Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept","volume":"1158","author":"Rozet","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.12.002_bib0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2007.06.032","article-title":"Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal \u2013 Part III","volume":"45","author":"Hubert","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.12.002_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.chroma.2007.03.111","article-title":"Analysis of recent pharmaceutical regulatory documents on analytical method validation","volume":"1158","author":"Rozet","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.12.002_bib0080","series-title":"Statistics and Chemometrics in Analytical Chemistry","first-page":"110","article-title":"Calibration methods in instrumental analysis: regression and correlation","author":"Miller","year":"2010"},{"issue":"Suppl. 5","key":"10.1016\/j.jpba.2013.12.002_bib0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00003495-198500295-00023","article-title":"Effect of renal function and dialysis on temocillin pharmacokinetics","volume":"29","author":"Boelaert","year":"1985","journal-title":"Drugs"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513005773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513005773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T03:24:45Z","timestamp":1538969085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513005773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":17,"alternative-id":["S0731708513005773"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.12.002","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a high performance liquid chromatography assay for the determination of temocillin in serum of haemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}